Sunday, April 21, 2024
HomeHealth EconomicsHSR Name for Abstracts: The Function of Well being Providers Analysis in...

HSR Name for Abstracts: The Function of Well being Providers Analysis in Advances in Most cancers Prevention and Management


Cross-posted from the Well being Providers Analysis web site.

Sponsored by: Division of Public Well being Sciences, College of Virginia Faculty of Drugs
Submission deadline for abstracts: Monday 17 June 2024

Well being Providers Analysis (HSR) and the Division of Public Well being Sciences, College of Virginia Faculty of Drugs are partnering to publish a Particular Problem on The Function of Well being Providers Analysis in Most cancers Prevention and Management. The particular concern shall be edited by Kevin Schulman, MD, Roger Anderson, PhD, Xin Hu, PhD, and Asal Pilehvari, PhD.

Paradigm shifts in most cancers screening reminiscent of mammography, colonoscopy, and Pap smears have been pivotal in detecting cancers at earlier and extra treatable levels. Therapies together with focused therapies, immunotherapies, and precision medication have extended disease-free intervals, improved total survival, and enhanced high quality of life for survivors. Interventions within the supply and high quality of palliative care and hospice utilization have improved the end-of-life expertise. Well being companies analysis has contributed considerably to evaluating the effectiveness, accessibility, and implementation methods of those screening packages, therapies, and interventions, guiding their integration into medical follow.

Nonetheless, challenges persist in making certain equitable entry to high-quality most cancers look after all. Disparities in most cancers outcomes based mostly on components together with socioeconomic standing, intercourse, gender identification, race, ethnicity, incapacity, comoribidities, care supply system, well being coverage, and geographical location stay a priority. Addressing these disparities and additional bettering most cancers prevention and management methods requires a complete software of well being companies analysis.

Well being companies analysis can contribute to understanding how integrating modern approaches of know-how reminiscent of synthetic intelligence (AI), predictive analytics, massive information analytics, and proof synthesis methodologies can enhance knowledgeable decision-making throughout the most cancers care continuum. Well being companies analysis may inform coverage improvements that promote entry to care, and patient-centered care approaches. All current alternatives to additional improve most cancers prevention and management and enhance affected person outcomes.

This particular concern will embrace empirical research that illuminate the appliance of well being companies analysis all through the most cancers care continuum, from prevention and early detection to therapy, survivorship, and end-of-life care. Examples of subject areas of curiosity embrace however will not be restricted to:

  • Analysis of most cancers care high quality indicators, most cancers care utilization and financial outcomes, and/or organizational buildings or designs related to effectivity and effectiveness of most cancers care supply.
  • Analysis of the usage of cutting-edge applied sciences, together with AI and machine studying:
    • to judge and/or quantify most cancers care high quality, utilization, and outcomes; or
    • as a medical software to enhance customized therapy choice, most cancers care high quality and utilization in real-world-applications, reminiscent of danger stratification, sample recognition, or improved diagnostic accuracy.
  • Era of data-driven suggestions to deal with the entry, value or high quality of most cancers look after key stakeholders throughout the most cancers management continuum, from prevention to end-of-life care, together with however not restricted to insurance coverage corporations, skilled societies, well being care suppliers, governments, sufferers and caregivers.

HSR is issuing a name for abstracts to ask paper submissions for this particular concern. The deadline for preliminary submission of abstracts is 17 June 2024.  Abstracts might not exceed 300 phrases and should be formatted as indicated within the HSR Creator Directions (Part 2.4.2.2, key phrases not needed).

Abstracts shall be evaluated by a multidisciplinary evaluation panel. Analysis standards embrace:

  • High quality, rigor, and originality
  • Relevance to the particular concern theme
  • Readability of writing and presentation.

Authors of abstracts that almost all intently match the factors shall be invited in August to submit full manuscripts in November 2024.

Invited manuscripts should observe the Creator Directions and endure the identical HSR peer evaluation course of as common concern manuscripts. Nevertheless, because of the strict timeline for publishing the particular concern, the evaluation and revision course of will observe an expedited timeline. Authors should be immediate in returning revisions. Invited articles shall be revealed on-line on acceptance. Some accepted articles won’t be chosen for the particular concern however shall be revealed in a daily concern.

The anticipated publication date for the particular concern is March 2026.

To submit an summary for consideration, please electronic mail it with the corresponding creator’s contact data to hsr@aha.org. Embody “Particular Problem HSR in Most cancers” within the electronic mail topic line.

Key dates for authors

Submission deadline for abstracts: 17 June 2024

Full manuscript invitation: 1 August 2024

Full manuscript deadline: 1 November 2024

Particular concern publication date: March 2026

Questions? Please electronic mail Kelly Teagle at hsr@aha.org.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments